Related Experiment Video
Updated: Apr 6, 2026
08:45
New Thrombectomy Technique for Total Portal Vein Thrombosis in Liver Transplantation
Published on: June 27, 2025
1.9K
[Chronic liver disease and thrombosis risk]
Duodecim; Laaketieteellinen Aikakauskirja
|August 5, 2015
Summary
Chronic liver disease increases thrombosis risk, particularly portal vein thrombosis in cirrhosis. This review guides anticoagulation therapy tailored to bleeding risk and proposes treatment algorithms.
Area of Science:
- Hepatology
- Vascular Medicine
- Thrombosis Research
Context:
- Chronic liver disease (CLD) and cirrhosis are associated with complex coagulopathy.
- This coagulopathy paradoxically increases risks for both bleeding and thrombosis, especially in the portal vein and splanchnic circulation.
- Portal vein thrombosis (PVT) in cirrhosis portends a poor prognosis and is linked to decompensation events.
Purpose:
- To provide practical guidance on tailoring anticoagulation therapy for patients with cirrhosis and portal vein thrombosis.
- To review the current understanding of hypercoagulability in chronic liver disease.
- To propose an integrated treatment algorithm for cirrhotic PVT incorporating anticoagulation and transjugular intrahepatic portosystemic shunts (TIPS).
Summary:
- Anticoagulation therapy can achieve recanalization in recent PVT and prevent progression in chronic cases.
- Standard thrombosis prophylaxis is recommended for hospitalized cirrhotic patients.
- Individualized anticoagulation strategies should balance thrombosis risk against bleeding risk in cirrhosis.
Impact:
- This review aims to optimize management strategies for PVT in cirrhosis, potentially improving patient outcomes.
- It offers a framework for clinicians to make informed decisions regarding anticoagulation in this complex patient population.
- The proposed algorithm may enhance the efficacy of combined anticoagulation and TIPS for treating cirrhotic PVT.
Related Concept Videos
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
337
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
337
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
257
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
01:24Chronic Pancreatitis I: Introduction
894
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
894
01:24Disorders of Hemostasis
2.8K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.8K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.4K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.4K
01:30Venous Thrombosis I: Introduction
700
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
700